Skip to main content
SpringerLink
Log in

Abnormal fatty acid pattern of the plasma cholesterol ester fraction in cystic fibrosis patients with and without pancreatic insufficiency

  • Original Investigations
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

In our previous work it was found that in cystic fibrosis patients with and without pancreatic insufficiency, the fatty acid pattern of the plasma long chain, non-esterified fatty acid fraction is strikingly abnormal in comparison with the corresponding pattern of healthy subjects. However, other investigators have shown abnormal fatty acid patterns only in patients with pancreatic insufficiency. Therefore, we studied the plasma cholesterol ester fraction in cystic fibrosis patients of both types by gas liquid chromatography. It was found that the absolute total concentration of the plasma cholesterol esters in cystic fibrosis patients with and also without pancreatic insufficiency is significantly lower than in healthy subjects.

Furthermore, the fatty acid pattern of this lipid fraction is significantly abnormal in both groups of patients, although to a lesser extent in patients without pancreatic insufficiency.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baran D, Loeb H, Mozin NJ (1976) Efficiency of two pancreatic extracts in patients with cystic fibrosis. Acta Paediatr Belg 29: 117–119

    Google Scholar 

  2. Burns GB, Dodge JA (1982) Elevated levels of 13,14-dihydro-15-keto prostaglandin metabolites and essential fatty acid deficiency in CF and heterozygote subjects. In: Proceedings 11th annual meeting European working group cystic fibrosis, June 2–4, Brussels, Belgium, p 76

  3. Caren R, Corbo L (1966) Plasma fatty acids in pancreatic cystic fibrosis and liver disease. J Clin Endocrinol Metab 26:470–477

    Google Scholar 

  4. Chase EP, Dupont J (1978) Abnormal levels of prostaglandins and fatty acids in blood of children with cystic fibrosis. Lancet 2:236–238

    Google Scholar 

  5. Chase HP, Cotton EK, Elliott RB (1979) Intravenous linoleic acid supplementation in children with cystic fibrosis. Pediatrics 64: 207–213

    Google Scholar 

  6. Crossley JR, Berryman CC, Elliott RB (1977) Cystic fibrosis screening in the newborn. Lancet 2:1093–1095

    Google Scholar 

  7. Davidson GP, Phelan PD, Townley RRW (1978) A controlled trial using intravenous infusion of soya oil emulsion in the treatment of children with cystic fibrosis. Aust Paediatr J 14:80–82

    Google Scholar 

  8. Elliott RB (1976) A therapeutic trial of fatty acid supplementation in cystic fibrosis. Pediatrics 57:474–479

    Google Scholar 

  9. Fernandes J, Van de Kamer JH, Weijers HA (1962) Differences in absorption of the various fatty acids. Studies in children with steatorrhea. J Clin Invest 41:488–494

    Google Scholar 

  10. Galabert C, Filliat M, Chazalette JP (1978) Fatty acid composition of serum lecithins in cystic fibrosis patients without steatorrhoea. Lancet 2:903

    Google Scholar 

  11. Hubbard VS, Dunn GD (1980) Fatty acid composition of erythrocyte phospholipids from patients with cystic fibrosis. Clin Chim Acta 102:115–118

    Google Scholar 

  12. Hubbard VS, Dunn GD, di Sant'Agnese PA (1977) Abnormal fatty acid compositions of plasma lipids in cystic fibrosis — a primary or a secondary defect? Lancet 2:1302–1304

    Google Scholar 

  13. Kuo PI, Huang NN (1965) The effect of medium chain triglyceride upon fat absorption and plasma lipid and depot fat of children with cystic fibrosis of the pancreas. J Clin Invest. 44: 1924–1933

    Google Scholar 

  14. Lloyd-Still JD, Johnson SB, Holman RT (1981) Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation. Am J Clin Nutr 34:1–7

    Google Scholar 

  15. Lloyd-Still JD, Simon SH, Wessel HV, Gibson LE (1979) Negative effects of oral fatty acid supplementation on sweat chloride in cystic fibrosis. Pediatrics 64:50–52

    Google Scholar 

  16. Malmendier CL, Van Den Bergen CJ, Baran D (1977) Influence of lyophilized total pancreas on plasma lipids and on fat absorption in cystic fibrosis. Helv Paediatr Acta 32:115–128

    Google Scholar 

  17. McCollum JPK, Matthias PN, Sciberras D, Mutter DPR, Newman C, Harries JT, Norman AP (1976) Factors influencing the serum concentrations of vitamin E and essential fatty acids in cystic fibrosis. In: Proceedings of the VIIth international cystic fibrosis congress, May 31–June 3, Paris, France, pp 316–322

  18. Reemstra K, di Sant'Agnese PA, Malm JP, Barker HG (1958) Cystic fibrosis of the pancreas: intestinal absorption of fat and fatty acid labeled I131. Pediatrics 22:525–532

    Google Scholar 

  19. Robinson PG (1976) 5, 8, 11 eicosatrienoic acid in red cells from patients with cystic fibrosis. In: Proceedings of the VIIth international cystic fibrosis congress, May 31–June 3, Paris, France, pp 107–110

  20. Robinson PG, Dodge JA (1980) Blood cell fatty acids in cystic fibrosis. In: Perspectives in cystic fibrosis, proceedings of the VIIIth international congress on cystic fibrosis, May 26–30, Toronto, Canada, p 31a

  21. Rogiers V (1977) The application of an improved gas-liquid chromatographic method for the determination of the long chain non-esterified fatty acid pattern of blood plasma in childen. Clin Chim Acta 78:227–233

    Google Scholar 

  22. Rogiers V (1980) Gas chromatographic determination of the fatty acid pattern of red cell membrane plasmalogens in healthy children. J Chromatogr 182:27–33

    Google Scholar 

  23. Rogiers V, Crokaert R, Vis HL (1980) Altered phospholipid composition and changed fatty acid pattern of the various phospholipid fractions of red cell membranes of cystic fibrosis children with pancreatic insufficiency. Clin Chim Acta 105:105–115

    Google Scholar 

  24. Rogiers V, Dab I, Crokaert R, Vis HL (1980) Long chain nonesterified fatty acid pattern in plasma of cystic fibrosis patients and their parents. Pediatr Res 14:1088–1091

    Google Scholar 

  25. Rogiers V, Mandelbaum I, Mozes N, Vertongen F, Dab I, Crokaert R, Vis HL (1982) “In vitro” study of the incorporation and transport of non-esterified fatty acids into the phospholipids of the red blood cell membranes of cystic fibrosis patients. Pediatr Res 16:761–768

    Google Scholar 

  26. Rosenlund ML, Kim HK, Kritchevsky D (1974) Essential fatty acids in cystic fibrosis. Nature 251:719

    Google Scholar 

  27. Rosenlund ML, Selekman JA, Kim HK, Kritchevsky D (1977) Dietary essential fatty acids in cystic fibrosis. Pediatrics 59: 428–432

    Google Scholar 

  28. Spehl-Robberecht M, Baran D, Dab I, Perlmutter-Cremer N (1980) Ultrasonic study of pancreas in cystic fibrosis. In: Perspectives in cystic fibrosis, proceedings of the 8th international congress on cystic fibrosis, May 36–30, Toronto, Canada, pp 215–219

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacognosy, Phytochemistry and Toxicology, Free University of Brussels, Belgium

    V. Rogiers & A. Vercruysse

  2. Department of Pediatrics, Free University of Brussels, Belgium

    I. Dab & D. Baran

Authors
  1. V. Rogiers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Vercruysse
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Dab
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Baran
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rogiers, V., Vercruysse, A., Dab, I. et al. Abnormal fatty acid pattern of the plasma cholesterol ester fraction in cystic fibrosis patients with and without pancreatic insufficiency. Eur J Pediatr 141, 39–42 (1983). https://doi.org/10.1007/BF00445666

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00445666

Key words

Search

Navigation